ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 547 filers reported holding ASTRAZENECA PLC in Q3 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,540,299 | +20.6% | 58,216 | +4.7% | 0.70% | +15.2% |
Q1 2024 | $3,766,048 | +41.3% | 55,587 | +40.5% | 0.61% | +18.1% |
Q4 2023 | $2,664,718 | -5.2% | 39,565 | -4.6% | 0.51% | -16.0% |
Q3 2023 | $2,809,737 | -5.4% | 41,491 | -0.1% | 0.61% | +4.1% |
Q2 2023 | $2,971,180 | +4.3% | 41,514 | +1.1% | 0.59% | +10.1% |
Q1 2023 | $2,849,772 | +4.3% | 41,057 | +1.9% | 0.53% | -9.8% |
Q4 2022 | $2,731,554 | +34.4% | 40,288 | +8.7% | 0.59% | -24.5% |
Q3 2022 | $2,032,000 | -22.3% | 37,061 | -6.4% | 0.78% | -1.0% |
Q2 2022 | $2,615,000 | -13.5% | 39,583 | -13.1% | 0.79% | +17.4% |
Q1 2022 | $3,022,000 | +26.5% | 45,560 | +11.1% | 0.67% | +61.2% |
Q4 2021 | $2,389,000 | +1.2% | 41,011 | +4.3% | 0.42% | -8.5% |
Q3 2021 | $2,361,000 | +4.2% | 39,315 | +4.0% | 0.46% | +4.6% |
Q2 2021 | $2,266,000 | +24.2% | 37,821 | +3.1% | 0.44% | +14.1% |
Q1 2021 | $1,825,000 | +7.0% | 36,701 | +7.6% | 0.38% | -6.4% |
Q4 2020 | $1,705,000 | -12.4% | 34,106 | -4.0% | 0.41% | -23.0% |
Q3 2020 | $1,947,000 | -2.2% | 35,535 | -5.6% | 0.53% | -16.1% |
Q2 2020 | $1,990,000 | +63.2% | 37,629 | +37.9% | 0.63% | -25.4% |
Q1 2020 | $1,219,000 | -69.1% | 27,288 | -65.5% | 0.85% | -32.8% |
Q4 2019 | $3,946,000 | +13.7% | 79,150 | +1.6% | 1.26% | +6.2% |
Q3 2019 | $3,470,000 | +11.2% | 77,866 | +3.0% | 1.19% | +8.7% |
Q2 2019 | $3,121,000 | +5.7% | 75,608 | +3.5% | 1.09% | +1.3% |
Q1 2019 | $2,953,000 | +16.6% | 73,045 | +9.5% | 1.08% | -15.7% |
Q4 2018 | $2,533,000 | -3.2% | 66,695 | +0.8% | 1.28% | +21.4% |
Q3 2018 | $2,618,000 | +12.4% | 66,159 | -0.3% | 1.06% | +5.5% |
Q2 2018 | $2,329,000 | -9.4% | 66,325 | -9.8% | 1.00% | -8.1% |
Q1 2018 | $2,572,000 | -10.6% | 73,549 | -9.6% | 1.09% | -14.5% |
Q4 2017 | $2,878,000 | +5.6% | 81,333 | +2.2% | 1.27% | -4.9% |
Q3 2017 | $2,726,000 | +3.3% | 79,579 | +2.8% | 1.34% | -11.9% |
Q2 2017 | $2,640,000 | +7.7% | 77,443 | -1.7% | 1.52% | +10.6% |
Q1 2017 | $2,452,000 | +4.9% | 78,753 | -8.0% | 1.37% | +26.6% |
Q4 2016 | $2,338,000 | -24.8% | 85,587 | +2.4% | 1.08% | -17.2% |
Q3 2016 | $3,111,000 | +25.9% | 83,604 | +2.1% | 1.31% | +5.5% |
Q2 2016 | $2,471,000 | – | 81,855 | – | 1.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |